Company intelligence / Profile preview

The Grasses of Eden

Carmel or Moshav Carmel, Israeldnb.com ↗

Ownership: Private
Development stage: Other

Overview

The company sponsored clinical research into natural/herbal-based interventions for respiratory conditions in children, including a post-market study confirming the benefit of a seawater-based nasal spray with antibiofilm properties. No advanced pharmaceutical clinical trial results are reported.

Therapeutic areas: ImmunologyInfectious Diseases
Modalities: Device (nasal spray with natural extract)Herbal/natural product-based therapies
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on The Grasses of Eden.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Grasses of Eden.

Explore the full profile